Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patients [1]

Schizophrenia Research

Volumn 49, Issue 1-2, 2001, Pages 223-225

  Dahmen, Nobert ^a   Müller, Matthias J ^a   Germeyer, Sabine ^a   Rujescu, Dan ^a,b   Anghelescu, Ion ^a   Hiemke, Christoph ^a   Wetzel, Hermann ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; FLUPENTIXOL; NEUROLEPTIC AGENT; TAQ POLYMERASE;

ALLELE; CAUCASIAN; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA FLANKING REGION; DOUBLE BLIND PROCEDURE; DYSKINESIA; EXTRAPYRAMIDAL SYMPTOM; GENETIC POLYMORPHISM; HIGH RISK POPULATION; HUMAN; LETTER; PARANOID SCHIZOPHRENIA; PARKINSONISM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0035870794     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(99)00147-4     Document Type: Letter

References (6)

1. A.C Altamura Drug-resistance phenomena in major psychoses: their discrimination and causal mechanisms Clin. Neuropharmacol. 13 Suppl. 1 1990 1 15
2. C.-G Chen F.-C Wei F.-J Koong K.-J Hsiao Association of TaqI A polymorphism of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia Biol. Psychiatry 41 1997 827 829
3. D.K Grandy Y Zhang O Civelli PCR detection of the TaqA RFLP at the DRD2 locus Human Mol. Genet. 2 1993 2197
4. J.M Kane D.V Jeste D.R.E Barnes D.E Casey J.O Cole J.M Davis C.T Gualtieri N.R Schooler R.L Sprague R.M Wettstein A task force report of the American Psychiatric Association 1992 American Psychiatric Association Washington, DC
5. L Lannfelt P Sokoloff M.P Martres C Pilon B Giros E Jönsson G Sedvall J.C Schwartz Amino acid substitution in the dopamine D3 receptor as a useful polymophism for investigating pdsychiatric disorders Psychiatr. Genet. 2 1992 249 254
6. V.M Steen R Loville T MacEvan R.G McCreadie Dopamine D3-receptor gene variant and susceptibility to rardive dyskinesia in schizophrenic patients Mol. Psychiatry 2 1997 139 145